AdipoGen Life Sciences

D-erythro-Dihydrosphingosine [Sphinganine]

CHF 50.00
In stock
AG-CR1-3556-M0055 mgCHF 50.00
NEW
More Information
Product Details
Synonyms Sphinganine (d18:0); Dihydrosphingosine; (2S,3R)-2-Aminooctadecane-1,3-diol
Product Type Chemical
Properties
Formula

C18H39NO2

MW 301.5
CAS 764-22-7
Purity Chemicals ≥95%
Appearance White to off-white solid.
Solubility Soluble in DMSO (20mg/ml) or ethanol (20mg/ml).
InChi Key OTKJDMGTUTTYMP-ZWKOTPCHSA-N
Smiles OC[C@H](N)[C@H](O)CCCCCCCCCCCCCCC
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description
  • The metabolite sphinganine activates the CD4+ regulatory T (Treg) cells, which accumulate in the tumor microenvironment (TME) and suppress the immune system. Sphinganine activates the Treg cells by physically interacting with the transcription factor c-Fos, and consequently increasing Treg cell proliferation.
  • Sphinganine is a precursor of ceramide and sphingosine as well as a substrate of sphingosine kinases, which generate sphinganine-1-phosphate.
  • Sphinganine is an inhibitor of protein kinase C and phospholipases A2 and D.
  • Sphinganine levels increase significantly in response to certain mycotoxins, including fumonisins, as well as in some cancers.
  • Sphinganine has been proposed to function as a c-Src kinase inhibitor in a drug-induced cancer cell model.
Product References
  1. Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases: A.H. Merrill, et al.; J. Biol. Chem. 261, 12610 (1986)
  2. Structural requirements for long-chain (shingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds: A.H. Merrill, et al.; Biochemistry 28, 3138 (1989)
  3. Sphingolipid metabolism and signal transduction: inhibition of in vitro phospholipase activity by sphingosine: R.C. Franson, et al.; Biochim. Biophys. Acta 1136, 169 (1992)
  4. Biomarkers of exposure to fumonisin mycotoxins: A review: G.S. Shephard, et al.; Food Addit. Contam. 24, 1196 (2007)
  5. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols: S.T. Pruett, et al.; J. Lipid Res. 49, 1621 (2008)
  6. Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers: J. Yin, et al.; FEBS Lett. 584, 1872 (2010)
  7. Secretion of Sphinganine by Drug-Induced Cancer Cells and Modified Mimetic Sphinganine (MMS) as c-Src Kinase Inhibitor: R. Nandangiri, et al.; Asian Pac. J. Cancer Prev. 25, 433 (2024)
  8. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos: S. Ma, et al.; Sci. Immunol. 9, eadg8817 (2024)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.